Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsutaro Akao is active.

Publication


Featured researches published by Mitsutaro Akao.


Antimicrobial Agents and Chemotherapy | 1993

Inactivation of rifampin by Nocardia brasiliensis.

Katsukiyo Yazawa; Yuzuru Mikami; Akio Maeda; Mitsutaro Akao; N Morisaki; S Iwasaki

Rifampin was glycosylated by a pathogenic species of Nocardia, i.e., Nocardia brasiliensis. The structures of two glycosylated compounds (RIP-1 and RIP-2) isolated from the culture broth of the bacterium were determined to be 3-formyl-23-(O-[beta-D-glucopyranosyl])rifamycin SV and 23-(O-[beta-D-glucopyranosyl])rifampin, respectively. Both compounds lacked antimicrobial activity against other gram-positive bacteria as well as the Nocardia species.


Biochemical Pharmacology | 1971

Metabolic degradations of nitrofurans by rat liver homogenate.

Mitsutaro Akao; Keiko Kuroda; Komei Miyaki

Abstract The evidence of the metabolic degradations of some nitrofurans by rat liver homogenate was shown in the present study. Nitrofurans were incubated with 8500 g supernatant of rat liver homogenate with added NADPH 2 as a hydrogen donor and metabolic degradations of nitrofurans were followed by the changes of their characteristic optical absorbances and the loss of their nitro groups. These two properties of most of the tested nitrofurans changed slowly and independently in aerobic condition. In anaerobic condition, they disappeared much more rapidly and nearly to the same extents.


Biochemical Pharmacology | 1980

Reduction by fumaric acid of side effects of mitomycin C

Keiko Kuroda; Mitsutaro Akao

Abstract The toxic symptoms in ICR mice given mitomycin C (either successive daily i.p. doses of l mg kg or two large doses of 4 mg kg ) were reduced by the concurrent administration of fumaric acid (40 mg kg ). Fumaric acid did not reduce the antitumor activity of mitomycin C against either the solid or the ascitic form of the Ehrlich tumor. Fumaric acid reduced the lethal and hematologie toxicities of mitomycin C, and studies on the nucleic acids of animal tissues indicated that mitomycin C inhibited selectively DNA synthesis of liver and kidney, whereas fumaric acid exerted an enhancing effect, antagonistic to mitomycin C, on DNA synthesis of these tissues.


Cancer Research | 1976

Inhibitory Effect of Capsella bursa-pastoris Extract on Growth of Ehrlich Solid Tumor in Mice

Keiko Kuroda; Mitsutaro Akao; Masayoshi Kanisawa; Komei Miyaki


Journal of the National Cancer Institute | 1987

Inhibitory Effect of Fumaric Acid on Hepatocarcinogenesis by Thioacetamide in Rats

Keiko Kuroda; Kiyoshi Terao; Mitsutaro Akao


Journal of the National Cancer Institute | 1982

Inhibitory Effect of Fumaric Acid on Forestomach and Lung Carcinogenesis by a 5-Nitrofuran Naphthyridine Derivative in Mice

Keiko Kuroda; Masayoshi Kanisawa; Mitsutaro Akao


The Journal of Antibiotics | 1992

SO-75R1, a new mutactimycin derivative produced by Nocardia brasiliensis.

Yuzuru Mikami; Katsukiyo Yazawa; Shinji Ohashi; Akio Maeda; Mitsutaro Akao; Masami Ishibashi; Jun'ichi Kobayashi; Chiji Yamazaki


Chemical & Pharmaceutical Bulletin | 1990

Inhibitory effect of fumaric acid on hepatocarcinogenesis by thioacetamide in mice.

Mitsutaro Akao; Keiko Kuroda


Journal of the National Cancer Institute | 1983

Inhibitory Effect of Fumaric Acid on 3-Methyl-4′-(dimethylamino)azobenzene-Induced Hepatocarcinogenesis in Rats

Keiko Kuroda; Kiyoshi Terao; Mitsutaro Akao


Japanese Journal of Cancer Research | 1986

FUMARIC ACID ENHANCES DNA SYNTHESIS OF RAT HEPATOCYTES BY COUNTERACTING THE TOXICITIES OF MITOMYCIN C AND AFLATOXIN B1

Keiko Kuroda; Mitsutaro Akao; Kiyoshi Terao

Collaboration


Dive into the Mitsutaro Akao's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge